Demystifying the Human Endocannabinoid System
Have you ever wondered why cannabis has such an effect on us? Well, thank the endocannabinoid system or the ECS. The ECS is a rich, complicated network of receptors in our brain and our gut which helps regulate the body’s natural state of homeostasis. The ECS is the most extensive biological system of receptors in our bodies. It helps regulate mood, appetite, memory, sleep and even fertility. If our bodies become injured, or fall out of homeostasis, this signals the ECS to kick in. And it is not just humans that have an ECS; virtually every animal on the planet has one. In this piece, we look back at history, to the first discovery of the ECS and how – over the years – we have come to understand its complete function and how it works inside our bodies to regulate homeostasis.
The discovery of the endocannabinoid system
The first outlines of the ECS emerged in the 1960s. At that time, scientists were successful in isolating numerous compounds from the cannabis plant known as phytocannabinoids (“phyto” meaning “plant”). Research into their effects on the human body revealed a whole web of receptors, enzymes and bio-chemical pathways involved in the manufacturing and use of the body’s own cannabinoids (known as endocannabinoids, “endo” meaning “originating from inside the body”). Although research focused primarily on humans and mammals, it was also discovered that we shared these neurochemicals with most members of the animal kingdom, including birds, amphibians, fish and even sea urchins.
What function does the endocannabinoid system serve?
The ECS is crucial in early development and throughout our lives. We are born with an ECS. In our early years, it mediates multiple processes of neurodevelopment, including cognition, perception, motivation, salience and regulation of fear. It is also crucial in something called synaptogenesis, which is the formation of synapses in our brain. Synapses are the little electrical connections that allow neurotransmitters to send information throughout our bodies.
What are the primary components of the endocannabinoid system?
The ECS is comprised of three primary components: receptors, endocannabinoids and enzymes.
Receptors receive and translate messages transmitted by cannabinoids. Through consuming cannabinoids, we are able to stimulate these receptors, which can increase our appetite, decrease inflammation, help with insomnia and even help with symptoms related to epilepsy. The ECS has two types of receptors: CB1 receptors and CB2 receptors. CB1 receptors exist in the brain and spinal cord, working to regulate appetite, memory and reduce pain. CB2 receptors exist within the immune system, working primarily to reduce inflammation throughout the body. Inflammation is the process the body undergoes to heal infected or damaged areas in the body. It is also a main cause of many different medical conditions.
Endocannabinoids, or endogenous cannabinoids, are cannabinoids produced naturally inside of the body. Endogenous cannabinoids contrast to exogenous cannabinoids, or cannabinoids found outside of the body, which sit on the shelves of most health shops today. When an imbalance is detected within our internal environment, our body synthesises endocannabinoids that interact with the cannabinoid receptors. This stimulates a chemical response that works to return the physiological process back to homeostasis. The endocannabinoids act as “keys”, while the receptors act as “locks”. Imagine that, every time one key fits into one lock, that connection causes an effect on the body. The are two main types of endocannabinoids in the body: Anandamide and 2-AG. Anandamide, commonly referred to as “the bliss molecule”, is responsible for runner’s high and the blissful states that come from things like yoga and meditation. 2-AG is the most prevalent endocannabinoid, responsible for managing appetite, pain response and immune system functions.
Enzymes are any substance within the body that cause chemical reactions to occur. Enzymes act within the ECS to recycle used endocannabinoids after the body is done with them.
Today, the ECS is helping us understand how cannabis works in our body. Research is now exploring how various cannabinoids can help regulate our natural state of homeostasis. However, while the ECS can help us understand the effect of different cannabinoids, cannabinoids are not the reason why the ECS exists. It is a biological system that has always been a part of us. And while the ECS performs different tasks, it always has one goal in mind: homeostasis, which is to keep our cells and immune system healthy.
FLWR: The Rize Medical Cannabis and Life Sciences UCITS ETF
 National Center for Biology Information, “Cannabinoid pharmacology: the first 66 years”, 2006. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760722/
 BBC, “Cannabis-based medicine for epilepsy available on NHS from January”, December 2019. Available at: https://www.bbc.com/news/health-50874089
 National Center for Biology Information, “Pharmacology of cannabinoid CB1 and CB2 receptors”, 2020. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9336020
 Healthline, “A Simple Guide to the Endocannabinoid System”, 2020. Available at: https://www.healthline.com/health/endocannabinoid-system-2
 Frontiers in Neuroscience, “Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease”, August 2016. Available at: https://www.frontiersin.org/articles/10.3389/fnins.2016.00321/full
 Virginia Pharmacists Association, “Role of Medical Marijuana and Cannabidiol (CBD) in Patient Care”, November 2019. Available at: https://virginiapharmacists.org/event/rphas-role-of-medical-marijuana-and-cannabidiol-cbd-in-patient-care/
 ScienceDirect, “2 Arachidonoylglycerol”, 2010. Available at: https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/2-arachidonoylglycerol
 National Center for Biology Information, “The Endocannabinoid System of Animals”, September 2019. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770351/